Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H17NO3 |
| Molecular Weight | 271.3111 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC[C@@H]1O[C@@H](CC2=C(O)C(O)=CC=C12)C3=CC=CC=C3
InChI
InChIKey=SUHGRZPINGKYNV-GJZGRUSLSA-N
InChI=1S/C16H17NO3/c17-9-15-11-6-7-13(18)16(19)12(11)8-14(20-15)10-4-2-1-3-5-10/h1-7,14-15,18-19H,8-9,17H2/t14-,15-/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex? | 2004 |
|
| Differences between A 68930 and SKF 82958 could suggest synergistic roles of D1 and D5 receptors. | 2005 Nov |
|
| Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists. | 2005 Oct |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
A-68930
Created by
admin on Fri Dec 15 18:00:32 GMT 2023 , Edited by admin on Fri Dec 15 18:00:32 GMT 2023
|
PRIMARY | |||
|
130465-45-1
Created by
admin on Fri Dec 15 18:00:32 GMT 2023 , Edited by admin on Fri Dec 15 18:00:32 GMT 2023
|
PRIMARY | |||
|
122324
Created by
admin on Fri Dec 15 18:00:32 GMT 2023 , Edited by admin on Fri Dec 15 18:00:32 GMT 2023
|
PRIMARY | |||
|
B4NI77O5D4
Created by
admin on Fri Dec 15 18:00:32 GMT 2023 , Edited by admin on Fri Dec 15 18:00:32 GMT 2023
|
PRIMARY | |||
|
DTXSID70926748
Created by
admin on Fri Dec 15 18:00:32 GMT 2023 , Edited by admin on Fri Dec 15 18:00:32 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
